The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
D000818:Animals; D001589:Benzphetamine / Q000378:metabolism; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D006834:Hydrazines / Q000378:metabolism*; D007700:Kinetics; D008862:Microsomes, Liver / Q000378:metabolism; D009249:NADP / Q000494:pharmacology; D009569:Nitric Oxide / Q000032:analysis; D009602:Nitrosamines / Q000032:analysis; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D012451:Safrole / Q000378:metabolism; D013053:Spectrophotometry
D065607:Cytochrome P-450 Enzyme Inhibitors; D006834:Hydrazines; D009602:Nitrosamines; D004364:Pharmaceutical Preparations; D010880:Piperidines; D001589:Benzphetamine; D009569:Nitric Oxide; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D012451:Safrole